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CONTINUING ONCOLOGIC CARE IN THE WAKE OF AN 
ENVIRONMENTAL DISASTER 
MEGAN MARIE MERRITT 
ABSTRACT 
Background 
Chronic, non-communicable diseases (NCD), such as cardiovascular disease and cancer, 
have overtaken communicable disease as the leading cause of morbidity and mortality 
worldwide. However, despite the substantial toll these diseases have on populations, 
patients suffering from these illnesses are often overlooked in the aftermath of an 
environmental disaster. Without proper disaster preparedness, these populations are often 
left vulnerable: without access to disease-modifying treatments or life-saving therapies.   
Objective 
This is a proposed disaster event health initiative for incorporating oncology care into 
disaster relief services worldwide. This study hypothesizes that with increased access to 
providers, resources, and cancer therapies during a disaster event, interruptions in patient 
oncology care will be minimized.  
Methods 
This disaster event health initiative consists of a detailed proposal for deploying a 
specialized oncology unit alongside traditional disaster response teams in an effort to 
decrease interruptions in patient oncology care. Depending on the severity of the disaster, 
available adjunct healthcare facilities, potential length of stay, most commonly used 
cancer therapies, and traditional patient: provider ratios, this proposal will inform the 
	  	   vi 
oncology unit assembly. Study measurables, such as how many patients seen, cancer 
diagnoses encountered, and most frequently used cancer therapies, will be collected using 
a standardized form. In addition, information regarding perceived patient satisfaction will 
be collected. System variable measures will be analyzed using frequency and average 
means whereas qualitative information will be coded for emerging themes. These 
measures of initiative efficacy will be used to revise and optimize future unit 
deployments.  
Conclusion 
Worldwide morbidity and mortality from non-communicable diseases, such as cancer, are 
steadily increasing. When acute environmental disasters strike, access to essential 
healthcare resources is disrupted, leaving these vulnerable populations without life-saving 
therapies they desperately need. These interruptions in cancer treatment plans result in 
poorer, long-term patient outcomes, compounding the effects of the disaster situation. By 
deploying a specialized oncology unit with disaster response teams during the initial 
recovery process, interruptions in cancer care will be minimized, ultimately decreasing 
long-term morbidity and mortality outcomes in this vulnerable patient population.  
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INTRODUCTION 
Background 
As the world continues to advance and evolve, with it comes a distinct transition in 
disease pathology. The healthcare field, once dominated by transmittable, communicable 
diseases, has been transformed. As of the last ten years, chronic, non-communicable 
diseases (NCDs) have now surpassed communicable disease as the number one cause of 
death worldwide.1 And yet, despite this transition, global efforts to mitigate morbidity 
and mortality as they relate to NCDs, in the wake of an acute environmental disaster 
event, have yet to follow suit. While the incidence and frequency of global natural 
disasters, such as earthquakes and hurricanes, have steadily increased over the last quarter 
century, only minor consideration has been given to vulnerable populations, such as 
patients with cancer and other non-communicable diseases, that are suffering from 
chronic and often debilitating illnesses. In a world that now sees over 38 million deaths 
per year from NCDs alone2, it is no longer enough to focus solely on the immediate result 
of the disaster event; we must also consider the specific needs of these vulnerable 
populations when planning, preparing, and responding.  
 
Statement of the Problem 
The incidence and frequency of global natural disasters has been steadily increasing over 
the last quarter century, leaving death and destruction in their wakes. Over 217 million 
people per year are affected as a result of these disasters,3 constituting a humanitarian 
crisis with no signs of alleviation. Environmental disasters such as hurricanes, floods, and 
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earthquakes have sparked the development of a global rapid response, with teams all over 
the world ready to deploy at a moment’s notice. Much of the response to a natural 
disaster is centered on the acute phase; the initial response to urgent medical needs that 
have arisen as a consequence of the immediate event.4,5 While imperative, this phase 
unfortunately often excludes care for those in vulnerable subgroups; such as the 
physically or mentally disabled, the homeless, the elderly, and those with chronic or 
terminal illnesses that are often exacerbated and overlooked during an acute disaster.4,6  
 A complete and thorough humanitarian response must incorporate all vulnerable 
subgroups; however, one particular group whose routine care is often interrupted and 
overlooked during a disaster event are those individuals with non-communicable diseases 
(NCDs). With the ‘disease transition’6 from communicable diseases to NCDs as the 
leading cause of morbidity and mortality worldwide, global response to natural disasters 
must expand to incorporate these populations as well. Cardiovascular disease (CVD), 
cancer, chronic respiratory disease, and diabetes are four of the main NCD subgroups 
worldwide, accounting for 82% of NCD related deaths.2 Deaths from cancer in particular 
total over 8.2 million per year, making cancer related mortality the second leading cause 
of NCD death, second only to CVD.2  
 Without specific considerations for patients with cancer when planning and 
responding to a disaster event, the effects are often devastating. Natural disasters impede 
access to and availability of clean water, food, proper sanitation, and “essential public 
health treatment options and equipment,”6 that leave these vulnerable populations with a 
profound decreased access to care and/or medication loss.4,6 Limited research has shown 
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that interruptions in or prolongation of cancer treatment plans in particular results in 
poorer loco-regional disease control, less disease-free survival years, and early death.6–10 
Despite this knowledge, oncologic care has yet to be included in the preparation for, 
planning of, or response to a natural disaster, leaving this massive population of patients 
suffering from their illness without access to treatments, including chemotherapy, 
radiation therapy, pain control medications, and anti-emetics, that they desperately need.  
 While access to therapeutic interventions is paramount, it is also imperative that 
response teams consider the co-morbidities of those currently in treatment. Patients who 
have either received chemotherapy or radiation therapy, or suffer from an illness that 
compromises their immune system, are unable to fight off infection. The internal 
displacement monitoring centre (IDMC) estimates that more than 19.3 million people left 
their homes due to disasters in 2014 alone.11 Those who are displaced are often forced 
into close quarters with thousands of others, and with limited access to shelter and clean 
sanitation, this situation is deadly for someone who is immunocompromised. Advanced 
planning and preparation can decrease the unnecessary morbidity and mortality for 
patients such as these.  
 The importance of the continuity of oncologic care in the wake of a natural 
disaster cannot be ignored; it is no longer acceptable to overlook this population when 
planning global preparedness or response. By incorporating an oncology component into 
the immediate disaster response, a large and vulnerable population receives the care and 
compassion they deserve.  
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Hypothesis 
Deploying an oncology-focused component as part of a disaster response team during an 
acute disaster event reduces interruptions in oncology care in the affected cancer 
population.  
 
Objectives and specific aims 
A proposal will be developed for incorporating oncology care during the immediate 
response to a natural disaster event. The proposal will consider elements such as the 
severity of the acute disaster event, whether near-by healthcare facilities and resources 
remain functional, potential length of oncology unit stay in the recovery zone, most 
commonly used cancer treatments and resources needed for this specific patient 
population, and traditional patient: provider ratios, to inform the oncology unit assembly. 
Based on current guidelines and practices when deploying a disaster response team to 
provide aid, this proposal will incorporate an oncologic component to be deployed 
alongside these teams during the initial recovery response. 
1.   Develop a detailed proposal for incorporating oncologic care into the acute phase 
response to a natural disaster event  
2.   Adjust proposal efficacy using analysis of standardized project variables 
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REVIEW OF THE LITERATURE 
Overview 
With the 21st century came modern advancements in the healthcare field that have 
revolutionized not only the way we diagnose and treat medical illness, but have 
transformed the clinical profile of the patient considerably. While populations continue to 
live longer, their lifestyles have become more sedentary, their weight increasing 
dramatically. Over the past ten years, this change in patient lifestyle has led to a global 
“disease transition” where NCDs have now surpassed communicable, maternal, perinatal, 
and nutritional diseases as the leading cause of morbidity and mortality worldwide.1,2,6 
Estimates believe NCDs are now responsible for between 60-65% of annual global 
mortality and greater than 54% of disability-adjusted life years (DALYs) globally.2,10,12 
While most believe this burden lies solely in high-income countries, in-fact over 80% of 
NCD related morbidity and mortality occurs in low- and middle-income countries 
(LMIC); a direct reflection of the undeniable socioeconomic disparities that plague these 
populations.2,10,12  
As a consequence of their lower socioeconomic status, populations in LMIC have 
greater contact with and increased access to disease risk factors, such as tobacco and 
alcohol use, physical inactivity, and unhealthy food choices, that have led to an increased 
incidence and prevalence of NCDs.1,2 Specifically, risk factors such as these have led to a 
striking increase among the top four NCD killers (Table 1).  
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Table 1. Top four causes of global NCD-related deaths and their annual mortality 
rates as reported in GLOBOCON 20122 
 
NCD  Annual deaths (million) 
CVD 17.5  
Cancer 8.2 
Respiratory Disease 4.0 
Diabetes 1.5 
 
Together, these four categories of NCDs account for over 82% of NCD – related 
deaths worldwide.2 Increases in NCDs such as these cause excessive strain on household 
resources by commanding scarce and valuable income be allocated toward healthcare 
costs. Lack of financial resources perpetuates the cycle of poverty, disallowing these 
populations to escape the constraints of their socioeconomic status, ultimately increasing 
their risk for NCD – related deaths. And yet, while this cycle continues to hinder 
populations, worldwide, on a daily basis, the effects to these vulnerable patients’ health 
are detrimental when medical services and resources are acutely disrupted.  
Over 217 million people per year are affected by disaster events.3 While many 
define the severity of a disaster based on their level of personal involvement, a disaster is 
often simply an “overwhelming and unforeseen event.”13 While war-time conflict and 
complex humanitarian emergencies (CHEs) are some of the most debilitating disasters, 
with mass effects on population morbidity, mortality, and country-wide economic 
outcomes, this focus of this paper rests with acute disaster events and the immediate 
recovery process. (Table 2)13 
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Table 2. Classifying disaster events     
ACUTE EVENT CHRONIC EVENT 
Disasters from forces in nature  
Tropical storms (hurricanes, 
cyclones) 
Floods 
Droughts 
Extreme heat or cold  
Volcanoes  
Earthquakes 
Landslides 
Tsunamis 
 
Complex Humanitarian Emergencies 
(Armed conflict)  
Disasters with humans as a factor 
Mudslides from deforestation 
Famine  
Desertification 
Disasters caused by humans  
Industrial events 
Transportation events 
  
When attempting to define an acute disaster event, one must take into account not 
only the extent of the physical damage, but also the resulting effect on the global, local, 
and individual levels. For most, “there is no single measure of a disaster that can capture 
the full scope of a disaster.”13 While some may use the economic impact, others measure 
impact by lives lost. Regardless of the method of measure, in order to think critically 
about the effect of a natural disaster, one must look at both the immediate effects and 
long-term implications for these populations.  
By and large the most frequent acute disaster events are those caused by forces of 
nature; tropical storms, droughts, and extremes in temperature top the list for loss events 
worldwide in 2014.14 From 2005-2014, China ranked highest with most disasters 
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reported; however, the US reported the most in damage, totaling over $443 billion dollars 
as opposed to $265 billion China reported over the same time frame.15 In 2015 alone, 
over 346 acute disaster events were reported, with over 22,000 deaths, 98.6 million 
people affected, and an economic toll greater than 66.5 billion dollars.16 While higher 
income countries like China and the US are reporting more disasters, unfortunately, the 
impact of a natural disaster event is often felt hardest in those LMIC; “LMICs face a 
greater burden of natural disasters…relative to high income countries as a result of 
relatively weak national health systems, higher levels of absolute and relative poverty, 
rapid urbanization, and associated planning deficiencies.” Those who are economically 
disadvantaged have traditionally been forced to overcome disparate numbers of obstacles 
in order to secure adequate healthcare protection; in a disaster situation, these obstacles 
become insurmountable. Knowing this, as well as knowing that an enormous burden of 
NCDs reside in LMIC, one must ask the question why NCDs are not yet a central focus 
of disaster recover efforts.  
While acute trauma related injuries are the leading cause of morbidity and 
mortality in the immediate aftermath of the disaster, deaths in the weeks following are 
often secondary to poor hygiene and lack of sanitation, insufficient nutrition and food 
supply, and decreased access to healthcare services as a result of damage and destruction 
to healthcare infrastructure and resources.6,12,17,18 Acute disaster events present healthcare 
access problems that are multifactorial. A disaster situation strains any health system, 
altering the way in which populations utilize health services and medical resources.5 Not 
only do they disable available transportation services and dismantle economies, they 
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“lead to community-level breakdowns in health infrastructure, evoking disruptions in 
access to and availability of health services, pharmacies, medical provider supply, and 
medical equipment.”6 Because of this, natural disasters have compounding effects on the 
NCD burden; in populations where NCDs are now the leading cause of death, these 
factors interact synergistically, which results in an increase in NCD incidence, as well as 
progression of NCD diseases.12 Without access to adequate nutrition, medical providers, 
and disease treatments, disaster events exacerbate existing NCDs, causing rapid clinical 
deterioration and acute complications.10,12 These complications ultimately result in poorer 
long-term prognoses, impaired quality of life and livelihoods, increases in morbidity of 
chronic diseased, and increased overall patient mortality.10,12,17  
And yet, despite the disease transition and knowledge that areas with the highest 
prevalence of NCDs are hit hardest by acute disaster events, global efforts to mitigate 
morbidity and mortality in the wake of a disaster have yet to follow suit. Acute 
environmental disasters have generated development of multiple global rapid response 
teams. However, much of these response teams offer assistance that is centered on the 
urgent medical of the affected population.5 This initial response typically includes 
consideration for conditions such as trauma-related injuries, communicable diseases, like 
diarrheal and respiratory illnesses, and relatively recently, more emphasis on 
psychosocial and mental health care.17 However, “the provision of care for chronic 
diseases is rarely seen as a priority.”17 These disasters create a “secondary surge”5 in both 
medical need and unfortunately, patient casualties, as the patient profile shifts from those 
needing trauma care to those in need of “non-disaster health needs”17 and chronic 
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healthcare. As Demaio et al highlights, “the outcome is greater morbidity [and mortality] 
resulting from a lack of evidence-based guidelines and a resulting healthcare gap for 
populations with chronic disease during and following emergencies.”12 
It is therefore imperative that, for a response effort to be considered truly 
successful, it must take into account care for those in vulnerable subgroups, such as the 
physically or mentally disabled, the homeless, the elderly, and those with chronic or 
terminal illnesses.4,6 Runkle et al defines the concept of “inverse care”, or those most in 
need of care are often the least likely to receive it in the weeks or months following a 
disaster, that affects these vulnerable populations.5 Cancer patients in particular fall 
victim to this theory, with chronic conditions that are often aggravated and overlooked in 
disaster preparedness and response. Globally, deaths from cancer total over 8.2 million 
per year, making cancer related mortality the second leading cause of NCD death, second 
only to CVD.2 Worldwide estimates report that in men, lung cancer has the highest 
incidence and results in the greatest number of deaths (figure 1A), whereas for women, 
breast cancer tops the charts for both measures (figure 1B).19  
 
	  11 
  
    A      B 
Figure 1. (A) Estimated age-standardized cancer incidence and mortality rates for 
men.19 (B) Estimated age-standardized cancer incidence and mortality rates for 
women.19  
 
In addition to worldwide variations among cancer diagnoses between males and 
females, incidence and mortality rates differed between the sexes across all regions of the 
world as well (figure 2). Estimates show that 57% of new cancer diagnoses and 65% of 
cancer deaths occurred in LMIC.19 
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Figure 2. Estimated overall age-standardized cancer incidence and mortality rates 
for both males and females as reported by GLOBOCON 2012.19 
 
Cancer incidence has increased as a direct result of  “the increasing aging of the 
world population, the adoption of unhealthy habits, such as smoking, sedentary lifestyle, 
and poor diet, sexually transmitted infections, [and] lack of access to health services for 
early detection and treatment.”20 Yet, despite this increase, this patient population is 
strikingly absent from policies and plans regarding the initial response to a disaster event.  
The cancer patient, mid-treatment, is a frightening enigma to most providers 
during times of disaster relief. While access to healthcare is often threatened regardless of 
the environment, it is often unattainable in the post-apocalyptic scenario. Kim et al 
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describes that in a “normal, non-disaster environment”, cancer patients often experience 
delays in receiving care9, therefore it comes as no surprise that during a disaster situation, 
where the stakes are high, care for this patient population is often disregarded. As a 
result, these patients lose their physical connection with their once life-saving treatment 
regimens, leaving them suffering from their disease, its progression, and its 
complications.   
While access to treatment is crucial, it is also imperative that response teams 
consider the co-morbidities and imminent complications of those currently in or have 
recently received treatment. Patients who have received chemotherapy or radiation 
therapy are often immunocompromised; their bodies are weak and unable to fight off 
infection. Disaster situations unfortunately cause increased overcrowding, inadequate 
access to sanitation and hygiene measures, insufficient shelter and decreased food supply, 
and water contamination that make these recovery zones increasingly unsafe for those 
with threatened immunity.12,21,22  
  
Figure 3. Tent cities in Croix-des-bouquets, Haiti, 9 months post 2010 earthquake. 
Photo credit to paper author.  
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Patients with little to no immune system, forced to survive in crowded, makeshift 
shelters without proper sanitation, are at an astronomical risk for infection and imminent 
death.  
Not only is concern for the immunocompromised patient a valid and important 
component to consider when planning and preparing to treat this population in a disaster 
event, but consideration for a patient’s comfort level must be included as well. It is 
reported that between 30-90% of patients with cancer are affected by pain throughout 
their illness, and up to 80% of those patients with a terminal diagnosis.20 These patients 
are reliant on medical therapies to alleviate their suffering. Yet, factors such as the 
inability to properly measure a patient’s pain, the arrogance-ignorance paradox of the 
medical profession with regard to pain and palliative services, insufficient medical 
knowledge about opioids and pain treatment, lack of pain medication, and legal 
difficulties obtaining and prescribing pain medications, cause substantial delay in 
receiving pain management services in the aftermath of a disaster.20 It is therefore 
essential that not only cancer prevention and current treatment modalities are an integral 
part of disaster response, but management of pain and palliation for those suffering must 
be considered as well.  
Although many succumb to acute injuries during disaster situations, those with 
cancer, a catastrophe of their own, are left suffering with no tailored medical care. Which 
now brings forth the question; amidst chaotic physical destruction, it is too outrageous to 
allocate resources and energy on those with an already limited life expectancy? Have we 
have already triaged them aside into the pile too resource intensive to try and salvage? If 
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the answer is no, then the next logical step is to include this population in future disaster 
preparedness and response in an effort to mitigate undue morbidity and mortality for 
these patients.  
 
Existing research 
As aptly identified by Demaio et al in their Call to Action, “a full assessment of 
evidence-based practice in assessing and treating chronic disease in disasters may not be 
plausible in the classical sense since this is more of a “modern era epidemic.”12 
Secondary to the relatively recent transition from communicable diseases to NCDs as the 
leading cause of death globally, limited research has been done to quantify or qualify the 
effects interruptions in NCD care may have on patients’ long-term morbidity and 
mortality. However, from what research is available with regard to interruptions in 
oncologic care specifically, it is evident that interruptions do have impactful negative 
outcomes in this patient population.   
 One retrospective cohort study, completed between 2005 and 2012, analyzed 750 
patients with colorectal cancer, examining the impact of chemotherapy use and delay on 
patient oncologic outcomes after their initial surgical resection. The study found a 
statistical difference in 5-year survival rates between those patients who received no 
chemotherapy (39.5%), those who received chemotherapy greater than eight weeks post-
resection (56.5%), and those who started adjuvant chemotherapy less than eight weeks 
post-op (80.1%) (p-value < 0.001).9 In addition, this study saw a significant difference in 
5-year cancer recurrence-free survival rates between the three groups, with a rate of 
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44.8% in the group receiving no chemotherapy, 39.6% in patients who received 
chemotherapy greater than 8 weeks post-resection, and a rate of 71.2% in those who 
received chemotherapy before 8 weeks after their surgical resection (p-value <0.001).9   
In one retrospective analysis out of Belgium, researchers aimed to evaluate local 
control rates for patients with laryngeal cancer after interruptions in their treatment 
course. Univariate analysis between those who received continuous radiation therapy for 
a variation of doses and treatment times, and those who received a split-course, or a 2-
week interruption in radiation treatment, showed those who received a split-course 
schedule had significantly lower local control rates (p-value 0.001), highlighting the 
negative effect of treatment interruption on local disease control.23 In addition, this study 
performed a multivariate analysis in an attempt to characterize the effects of overall 
treatment time on local disease control, finding that overall longer treatment times had a 
significant negative effect on local disease control (p-value 0.035).23 While these authors 
caution that several prognostic factors, such as larger tumor size or poorer health prior to 
receiving treatment, could influence local disease control, it stands that many who 
experience an interruption in cancer treatment or are treated for longer overall do in fact 
experience negative long-term outcomes.  
The findings in the aforementioned studies highlight how essential both access to 
and continuity of care are to a patient fighting cancer. Delays in initiating life-saving 
treatment modalities, interruptions in established oncologic treatment plans, or increased 
overall length of treatment have detrimental effects on both patients’ morbidity and 
mortality outcomes.  
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While these studies have shown that interruptions in cancer care do in fact result 
in adverse effects on patient morbidity and mortality outcomes, the next question posed is 
whether an acute disaster event causes significant interruptions for these vulnerable 
populations. One study, aimed at evaluating factors that affected access to head and neck 
cancer care in the wake of Hurricane Katrina, reports cancer prevalence in New Orleans 
in the year prior to the Hurricane estimated at 3.7%; however, in the year following the 
disaster, cancer treatment was reduced by 32.6%, demonstrating what a large impact the 
hurricane had on access to care and subsequently, treatment availability.24 This same 
study found that a reduction in access to cancer care following the Hurricane was 
significantly associated with difficulty obtaining cancer care when available (chi-square= 
48, p < 0.0001),24 highlighting the fact that of those who wished to access oncologic care 
in the wake of a disaster event faced significant difficulties in doing so. In addition, there 
was a significant association between those who felt there was less access to cancer care 
after the disaster and those who felt they would have sought care earlier if access had 
been improved (chi-square 32, p < 0.0001).24 This association shows that affected 
populations will in fact seek out and utilize care options if presented with them in the 
wake of a disaster.  
As highlighted in table 3, this study also found that factors typically considered 
prominent socioeconomic determinants of health were in fact not statistically associated 
with a patient’s access to cancer care.24 Despite traditional beliefs that those who are 
homeless, uninsured, or uneducated will have less access to healthcare regardless of the 
situation, this study shows that in disaster situations this is not always the case, stressing 
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a very real access problem with regard to cancer patients and the availability of their 
treatment options. 
Table 3. Additional factors analyzed to determine their influence on access to cancer 
treatment for those with head and neck cancer after Hurricane Katrina and their 
statistical significance.  
 
Factors influencing access to cancer 
treatment P-value 
Type of insurance 0.55 
Homelessness 0.51 
Access to transportation 0.85 
Smoking or Alcohol use history 0.32 
Level of education 0.18 
Time of presentation to EKL post-
hurricane 0.54 
 
One systematic literature review looked at what this access problem entails. Done 
to characterize the impact of cyclone, storm, and flood related disasters on NCD 
management, this study found that healthcare access was impeded by factors such as 
“damaged transport routes, reduced health services, loss of power and evacuations.”6  
 From the research cited above, it can be inferred that as disaster events present 
specific challenges to accessing healthcare and management plans for those with NCDs, 
the resulting treatment interruptions will result in poorer patient outcomes. While many 
have identified the access problem at hand, few have sought to quantify the actual impact 
these access issues have on patient morbidity and mortality outcomes in the wake of a 
natural disaster. The few studies that have been conducted show irrefutable evidence to 
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suggest these vulnerable populations do in fact suffer tangible consequences to their 
health.  
For some, the challenges NCDs pose are evident immediately following the 
disaster event. In the wake of the Sichuan earthquake in 2008, it was found that “up to 
38% of survivors needed clinical management of their pre-existing chronic medical 
conditions before further surgical interventions could be performed for their physical 
trauma.”17 Without on-site personnel equipped to manage these chronic conditions, over 
one-third of patients face imminent death.  
For others, the effects of the disaster situation unfold as the dust settles. One post-
hoc comparison that was completed following the 2010 Haiti earthquake analyzed data 
from the Belgian First Aid and Support Team (B-FAST), that was collected during and 
immediately following the earthquake, as well as data from the Medecins Sans 
Frontieres/ Doctors Without Borders (MSF) data obtained in the year prior to the 
earthquake. This study showed that while 90% of diagnoses in the first two weeks were 
injury related, there was a significant increase in diagnoses unrelated to acute trauma 
injuries in the three to five weeks following the earthquake (Table 4).18  
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Table 4. Diagnoses that emerged in weeks three-five following the 2010 Haiti 
earthquake as compared to those diagnoses recorded in the year prior to the 
disaster event 
 
Diagnoses Percent diagnosed (%) 99% CI 
Respiratory  16.5 14.8 – 18.4 
Ophthalmologic 4.2 3.3 – 5.3 
Digestive 10.7 9.3 – 12.3  
Neurologic 2.5 1.8 – 3.4  
Dermatologic 4.0 3.2 – 5.1 
Psychological 2.5 1.8 – 3.3 
 
This significant increase in diagnoses not related to acute trauma injury can be 
explained by understanding that the unique situation that results from disaster events, 
such as limited access to medical providers and medications, interruptions in treatment 
plans, and harrowing physical constraints from lack of food, shelter, and clean water, 
result in both exacerbations and increased incidence of NCD illnesses.  
A systematic literature review aimed at quantifying the effect of natural disasters 
on the prevalence of acute coronary syndrome (ACS) linked multiple disasters with an 
exacerbation of cardiovascular events. Specifically, the study saw that as an effect of both 
the 1994 Northridge earthquake and the September 11th World Trade Center attacks, 
there was a significant increase in acute myocardial infarction (AMI) event admissions 
both on the day of the earthquake (RR 1.83, 95% CI 1.29-2.59) and in the 60 days 
following the attacks (p-value 0.01).25  Additional results from the Ryan et al systematic 
	  21 
literature review describing the impact of cyclone, storm, and floods on NCD 
management found that disaster events increase the risk for severe exacerbation or 
disabling complications for those patients with cardiovascular disease, diabetes and 
chronic respiratory diseases.6 It was also found that for those patients with cancer 
specifically, a disaster event can impact access to transportation, providers, and 
medications, resulting in prolonged suffering and “an increased risk of premature death”6 
for these patients. These studies highlight how detrimental a disaster event is on 
morbidity and mortality of those patients with NCDs, illuminating the need for personnel, 
trained in NCD management, to travel alongside the first responders and provide 
lifesaving treatment to these vulnerable populations, keeping them from being just an 
afterthought.  
In addition to profound interruptions in treatment and management plans, disaster 
events pose additional obstacles for those patients with cancer. The very definition of a 
natural disaster is a summation of tribulations which threaten the life of an 
immunocompromised oncology patient. Researchers have found that “disasters can cause 
an exacerbation of NCDs or even death due to the limited access to treatment, care, 
medications, and transport; lack of food and clean water, and increased exposure to 
extremes of cold or heat.”6 Regarding the climate of post- 2010 Haiti earthquake has 
shown that a total of 37.8% (1057/2795) of patients developed features of an infection 
within the five weeks following the earthquake, almost twice the baseline number of 
infections recorded in the same period before and in the later years after the earthquake.18 
With an astounding 1.5 million people displaced from their homes, tent cities grew, and it 
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is therefore understandable that of the 667 internally displaced persons (IDP) analyzed in 
one study, up to 71% (667/934) presented with features of an infection.18,26 With 
increasing infection rates, one cannot expect a patient to survive when their immune 
system has been destroyed secondary to their oncologic illness or the treatment used to 
treat said illness. It is therefore imperative that not only personnel are available to 
mitigate this risk, but supplies, possible sterile environments, and treatments are available 
for those with weakened immune systems.  
While infection risk is a substantial and tangible complication of disasters that 
cancer patients face, their perception of pain as a direct result of their diagnoses and their 
ability to acquire the proper medications to treat their chronic pain, while less concrete, is 
nonetheless an important aspect of this population’s care following a natural disaster that 
must be taken into account as well. Although often underreported, pain prevalence has 
been reported as high as 59% in those patients receiving active treatment, 33% of 
survivors after treatment, and 64% of those with advanced or terminal disease.27 
However, in disaster situations, patients are placed at risk when they are forced to 
evacuate an area “without sufficient supplies of medication [or] pharmaceutical 
scripts/re-fills,”6 leaving the majority of those patients in active treatment or those who 
have completed treatment experiencing uncontrollable pain symptoms.  
In one qualitative study’s attempt to characterize veteran patients’ pain 
management after Hurricane Katrina, they found that there were major factors 
influencing a patients’ ability to to access pain management services during and 
following the Hurricane. The study cites pain medication being changed to less potent 
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formulations, pain medications stopped without replacement, inability to see a pain 
specialist, problems filling pain medication prescriptions, and running out or rationing 
medications as the main themes hindering access to pain management.28 Common themes 
that influenced whether or not a veteran rated their pain management services as 
“acceptable” or higher were cited as having access to their electronic medical record 
(EMR) as well as access to providers who were “willing to address their pain 
management condition with the same care as they addressed their medical and psychiatric 
issues, without undue fear of prescribing pain medications.”28 This study highlights 
certain modifiable factors, such as access to up-to-date EMR systems and experienced 
pain and palliative care providers, that disaster preparedness and planning frameworks 
must take into account when deploying response teams with chronic pain management 
end-goals.  
Despite the evidence that suggests acute disaster events cause interruptions in 
NCD care and management, few response-team interventions, employed to mitigate the 
resulting negative outcomes, have been implemented or studied. Despite being the 
second-leading cause of death globally, interventions with regard to cancer care 
management following a disaster event have yet to be employed, highlighting a very 
large and very real disaster relief gap. These patients require and deserve a primary 
response team whose initial thoughts are focused on them, their disease, their treatment 
course, and their pain. It is therefore essential that, moving forward, response planning 
and policies address this vulnerable population in an attempt to alleviate unnecessary 
morbidity and mortality. 	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METHODS 
Study Design 
This is a disaster event health initiative aimed at decreasing interruptions in oncology 
care during an acute environmental disaster event. This proposal will be used to aid in 
deployment of an oncology unit during a disaster event to promote continuity of 
oncologic care, as well as access to life-saving resources specific to this vulnerable 
population.  
 
Study population, sampling and recruitment 
The study population for this disaster event health initiative will be all patients with an 
oncology diagnosis whose previous oncology care is interrupted as a direct result of the 
disaster event. All eligible patients who present to the oncology unit will, at minimum, be 
seen by a clinical provider and provided with either additional educational or medical 
health services. Patients will be educated about these services by their primary 
oncologists prior to a disaster event. During the disaster event, patients will be recruited 
through word of mouth and necessity of medical services.  
 
Inclusion criteria:  
•   All patients with a cancer diagnosis prior to the disaster event.  
Exclusion criteria:  
•   Patients with no known previous cancer diagnosis 
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•   Patients who have an oncology diagnosis but have not yet started treatment are not 
eligible for continued chemotherapy treatment plans 
•   Patients who are, by clinical diagnosis, too sick for continued treatment will be 
ineligible for chemotherapy; however, these patients will receive available comfort 
measures as they pertain to their specific needs (i.e. palliative pain medication, anti-
emetics)  
•   Patients who are unable to answer medical questions for themselves, or do not have a 
next of kin available to answer medical questions, will be excluded from the post-hoc, 
qualitative analysis; however, these patients will still be eligible to receive medical 
treatment as deemed necessary by the clinical provider on-site  
Though it would have been optimal to utilize purposive sampling to recruit 
participants from several locations throughout the disaster zone, of varying ages, cancer 
diagnoses, and past and/or current treatment regimens, it will not be feasible for this 
study due to the nature of a disaster event and the proposed study sample population. For 
this reason, the study sample will be one of convenience for the sake of the post-hoc 
initiative evaluation.  
 Study population estimates will be based on a calculated 5-year world prevalence 
rates for all cancers (excluding non-melanoma skin cancers) of 0.44% (Appendix 2). 
Using this prevalence rate, an estimate for number of patients with a cancer diagnosis in 
varying population levels will be determined. These estimates will then be used to inform 
the total number of clinical providers the oncology unit should expect to deploy based on 
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the severity of the disaster event (scenario one vs scenario two) and how many patients 
are estimated to be affected (Table 5).  
 
Intervention  
This study proposes specific elements to consider when assembling a specialized 
oncology unit to deploy with initial disaster recover efforts in the context of two disaster 
event scenarios.  Scenario one considers an event that occurs in a high-income country, or 
in a region where healthcare infrastructure outside the disaster zone is optimal, whereas 
scenario two considers an event that occurs in a LMIC where oncology resources are 
scarce, or in a region where healthcare infrastructure outside the disaster zone is 
compromised or non-existent.  
 
Personnel 
Regardless of the disaster event scenario, the oncology unit will work under the incident 
commander and command staff team deployed with the disaster response team. The 
incident commander, logistics operator, safety officer, and administration officer will be 
trained prior to deployment in special considerations for oncology care in the affected 
patient population. In addition, a minimum of one supervising oncologist (MD) per 
disaster unit team must be deployed with each response unit. Lastly, if the event occurs in 
a region where English is not the primary language, the unit will deploy a minimum of 
one interpreter who speaks the region’s native language and/or the deployment team will 
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have access to satellite interpreter phones and video capabilities through a partnering 
interpreter service.   
With regard to the remainder of the clinical providers needed, using the 
calculated, 5 – year, world cancer prevalence rate of 0.44%, estimates for the number of 
patients with any cancer diagnosis (excluding all non-melanoma skin cancers) were 
determined for varying population sizes. For example, should an acute disaster event 
devastate a city with a population of 100,000 people, of that population, 440 patients will 
be expected to hold a cancer diagnosis. Using this, the number of additional personnel 
needed to triage and treat the estimated number of patients for each population size can 
be determined for each disaster event scenario (Table 5).   
Table 5. Estimated number of patients with a cancer diagnosis in varying 
population sizes, as calculated using the 5 – year, word cancer prevalence rate, and 
the resulting clinical provider estimates for triaging and treating these patients 
under each disaster event scenario.   
 
Population size 
of region 
affected 
(thousands) 
Estimated # of 
patients with 
cancer 
diagnosis 
SCENARIO 
ONE SCENARIO TWO 
Clinical 
Providers 
Clinical 
Providers 
Inpatient 
providers 
< 100 < 440 2 2 4 
100 – 200 440 - 880 2 - 4 2 - 4 4 – 8 
200 – 300 880 - 1320 4 - 5 4 - 5 8 – 10 
300 – 400 1320 - 1760 5 - 7 5 - 7 10 - 14 
400 – 500 1760 - 2200 7 - 8 7 - 8 14 - 16 
> 500 >2200 8+ 8+ 16+ 
 
 
For this initial proposal iteration, it will be assumed that one clinical provider can 
triage a maximum of 40 patients per day, spending an average of 15 minutes with each 
patient for a total of 10 hours a day. Clinical providers may be an MD, PA, or NP. 
Estimates assume that the total number of patients with a cancer diagnosis will be triaged 
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within one week. For example, one provider may see 40 patients per day, for 7 days, for a 
total of 280 patients. Knowing this, in a population with less than 440 patients with an 
estimated cancer diagnosis, the oncology unit will need 2 clinical providers to see and 
triage all patients in that time.  
The clinical providers deployed in scenario one, where patients are able to reach 
adjunct healthcare facilities, will focus on triaging oncology patients as they present to 
the disaster recovery zone. These providers will assess the severity of patient illness using 
patient illness history, including diagnosis and previous treatment modalities, current 
laboratory values, specifically immune and end-organ function, and their own clinical 
judgment. Patients needing immediate care, such as those with compromised immune 
systems, end-organ failure, or those in the middle of a treatment cycle, will be sent to 
participating adjunct healthcare facilities to receive this care. Participating facilities are 
those hospitals, clinics, and private oncology practices that, through prior state, federal, 
or national legislation, have agreed to see and treat patients with oncologic emergencies 
should a disaster event warrant relocation of oncology patients to their facility. For 
patients who have a current cancer diagnosis but are medically stable and are not 
currently receiving cancer treatment, clinical providers may provide illness education and 
information on when and where these patients can receive additional healthcare should 
they need it before their primary healthcare facility is fully operational again.   
The clinical providers deployed in scenario two, where patients are unable to 
reach adjunct healthcare facilities, will focus on triaging oncology patients as well as 
providing the necessary oncology care for the duration of the disaster recovery to ensure 
	  29 
minimized interruptions in care. Patients who are triaged and in immediate need of 
oncology care will be placed “inpatient”. “Inpatient” oncology patients are those who are 
in need of continuation of their chemotherapeutics, boarding in a “clean zone” for those 
with compromised immune systems, or medical care for patients with unrelenting 
pain/suffering attributable to their oncology diagnosis. It is then assumed that an 
“inpatient” clinical provider will be responsible for a maximum of 20 patients per day. 
Should all patients that are triaged in each population size range need inpatient level of 
care, estimates for inpatient providers are in addition to the “outpatient” clinical providers 
needed for triage services (Table 5).   
As with scenario two, for patients who have a current cancer diagnosis but are 
medically stable and are not currently receiving cancer treatment, clinical providers may 
provide illness education and information on when to return to the disaster recovery zone 
should they need additional oncology services.   
With respect to pharmacological and nursing services:  
 
Scenario one: 
•   One pharmacist per disaster unit team for overseeing anti-emetic and pain 
medication distribution, as well as for providing input to clinical providers 
regarding previous patient treatment regimens. No chemotherapeutics will not be 
brought with this recovery unit as part of scenario one as the hope is that patients 
who are in need of treatment continuity will be triaged to capable healthcare 
facilities nearby.  
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•   The unit will deploy between three to five registered nurses to aid in patient care 
and organization, lab draws, medication distribution, and project variable 
collection  
 
Scenario two:  
•   One pharmacist per 10 expected inpatient oncology patients per day for 
supervision of the distribution of oral/IV chemotherapies, pain medications, or 
anti-emetics. The team pharmacists will be responsible for inventory and 
distribution of these medications at all times. 
•   In addition to the registered nurses deployed to aid in “outpatient” care, based on 
the benchmark nurse to patient ratios as reported in the Labor Management 
Institute (2008)28 for inpatient oncology services, the unit will deploy one 
registered nurse to every five expected inpatients per day for assistance with 
laboratory collection, medication distribution, and in-house patient management. 
 
In addition to the personnel needed, table 6 outlines considerations for additional 
resources, such medications and special equipment, that the oncology unit must bring for 
successful completion of its task.  
Table 6. Medication and equipment resource considerations for deployment teams 
in both disaster event scenarios  
 
Resources Scenario One Scenario Two 
Medications 
Unit pharmacist:  
•   Access to a functioning local 
pharmacy OR  
Unit pharmacist(s):  
•   Anti-emetics  
•   Pain medications  
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•   Deployed with anti-emetics 
and pain medications 
commonly used in the area 
of the disaster  
 
•   Most commonly used 
oral/IV chemotherapeutics 
for the region of the 
disaster event.  
Equipment 
Mobile triage site:  
•   Tents, cots, linens, gowns, 
hand-held instruments (i.e. 
stethoscope)  
•   1-2 mobile hematology 
testing devices and sterile 
phlebotomy equipment for 
CBC and BMP analysis  
•   Food, such as meals ready to 
eat (MREs) and portable 
ultraviolet light water 
sanitation systems for 
staff/patients 
•   Mobile triage site, as 
detailed in scenario one 
 
•   Resources for a “clean 
zone” for patients with 
compromised immune 
systems. These resources 
may include tents, cots, 
linen, and other sanitizing 
or sterilizing equipment 
needed to prevent the 
spread of opportunistic 
infections 
 
For both scenarios, providers will be asked to complete a standardized form with 
project measurables for every patient who is triaged and/or treated by the oncology unit. 
In addition, each patient will be asked to complete a form with their identification 
information, as well as a patient satisfaction questionnaire, for future analysis.  
 
Study variables and measures  
A standardized form (Form A) will be sent with providers from each oncology. The 
following are system variables that will be included on the standardized form: 
 
System variables to be examined for each disaster site:   
•   Type of environmental disaster  
•   Patient identification number, to be given by the oncology provider on-site 
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•   Length of time patient was without oncology care immediately following the 
environmental disaster  
•   Number of patients triaged by a provider specialized in oncologic care 
•   Number of referrals to an appropriate facility able to continue the patient’s designated 
treatment plan during or after the disaster event 
•   Length of time spent with each patient  
o   <10 minutes  
o   10-30 minutes  
o   30-60 minutes 
o   >60 minutes  
•   Type and stage of cancer  
•   Treatment plans for patients designated prior to the disaster event  
o   Day & cycle of their treatment plan 
o   Prior surgical resections  
•   Treatments continued by a provider associated with the oncology unit (Dose, 
frequency, cycle number)  
On a separate form (Form B), labeled with the patient identification number given 
to the patient by the oncology provider (Appendix 1), patients will be asked to write their 
full name, date of birth (DOB), primary address, and contact information. These data will 
be collected for patient follow-up; ensuring these patients receive adequate and continuous 
care throughout the recovery process.  
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In addition, qualitative information regarding perceived patient satisfaction will be 
addressed. Patients will be asked how they became aware of the oncology services offered, 
and what ways they believe would be most helpful in informing others of these services in 
the future. Patients will be asked how satisfied they were with the care they received; 
whether they were triaged appropriately and whether or not their oncologic needs were met 
and interruptions in their care were minimized. These questions will be short answer and 
copies in the patients’ native language will be available.  
 
Data collection 
With regard to the standardized forms sent with the oncology unit, paper copies will be 
used while on-site in the recovery zone to minimize the need for electricity and ensure 
efficient reporting. Form A, the standardized form for system variables, is to be filled out 
by the provider who has direct contact with the patient. Form B and the patient satisfaction 
form are to be filled out by the patient or the patient’s next of kin.  
 While on-site in the recovery zone, Form A and the patient satisfaction form will 
be stored separately from Form B to protect patient identity and healthcare information. 
Form A and patient satisfaction forms will be kept in a locked office while not in use. Form 
B will be kept in a locked safe in a separate location when not in use.   
 Upon return from the recovery zone, patient data from Form A will be coded and 
entered into REDCap software, using only the patient identification number, for further 
analysis. Once data is entered into the software program, paper copies of Form A will be 
shredded. The patient satisfaction form will be transcribed into a Word document on an 
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encrypted laptop for further analysis. Once transcribed, the data from the patient 
satisfaction forms will be shredded as well.  
 Data from Form B will be transferred to a Microsoft Excel spreadsheet on an 
encrypted laptop. Once these data are entered, Form B will be shredded as well. These data 
will be analyzed alongside the data from the country’s cancer registry and updates to the 
registry will be made accordingly. 	   	  
 
Data analysis 
Using the system variables collected, analysis of patient demographics will be completed 
in an attempt to characterize the cancer populations receiving care as a direct result from 
this disaster event health initiative.  Frequency distributions and percentages will be used   
to summarize categorical measurements, while median (with range) will used to describe  
symmetric and skewed continuous measurements, respectively. Continuous variables will 
be analyzed using t-test for independent samples. Categorical variables will be compared 
using the Chi-square test.    
 A qualitative descriptive analysis approach will be used to analyze the patient 
satisfaction surveys. The primary researcher will code and recode the interviews until 
prominent themes and sub-themes emerged.  
 
Timeline  
As each disaster situation is unique depending on the type of disaster, the disaster 
severity, and the location and populations affected, the timeline for each initiative may 
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vary. The plan is for the oncology unit to be deployed with the initial disaster recovery 
team within 24 – 48 hours of the acute disaster event. The oncology unit will assemble in 
a central location alongside the response team, and will remain at the disaster site until 
healthcare infrastructure in the affected location can provide adequate oncologic care to 
the population. Oncology unit teams may be deployed in shifts lasting from 4 weeks to 6 
weeks, with the option for remaining on-site for those medical professionals who wish to 
do so.  
 
Institutional Review Board 
This disaster event health initiative will be submitted to the Boston University Medical 
Campus Institutional Review Board (IRB) for full board review. This study will collect 
project system variables through direct patient interaction, qualifying this as a study with 
human subjects. Patient data will not be de-identified as this population requires close 
patient follow-up during and after disaster recovery. In addition, as a component of this 
health initiative, patients in need of continued oncologic care will be offered access to 
chemotherapeutics and narcotic pain medications. While it is the belief that the benefits 
of continuing oncology care outweigh the negative patient outcomes of not providing 
these therapies, there are risks of adverse effects from these medications that are not to be 
taken lightly. For this reason, study approval will have to undergo a full board review.  
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CONCLUSION 
Discussion 
As chronic and non-communicable diseases step to the forefront of healthcare, with it 
must come evolution in the way these diseases are cared for and managed in all scenarios, 
disaster events included. No longer is it enough to plan and prepare for the initial 
recovery surge only; consideration for long-term morbidity and mortality outcomes as a 
consequence of the disaster, and the disaster’s effect on healthcare services and 
utilization, will shape the way response teams plan, prepare, and distribute healthcare 
throughout the entire recovery process. While imperative to continue to evolve all aspects 
of disaster response, it is the hope of this initiative that special considerations for 
vulnerable subgroups, specifically those suffering from cancer and its associated co-
morbidities, will bring much needed resources and relief to this population during and 
after a disaster event.  
The largest strength with regard to this health initiative is the novel nature of the 
research. While research has shown that interruptions in cancer treatment plans ultimately 
lead to poorer patient outcomes, this idea has yet to be studied during a disaster event; a 
time when healthcare infrastructure is often at its weakest. In addition, the strength of this 
study resides in its methodology; collecting system variables and perceived patient 
satisfaction throughout this initiative allows for constant revision of the proposal in an 
attempt to optimize not only the resources allocated, treatments provided, and patients 
reached, but allows for careful monitoring of morbidity and mortality outcomes in future 
studies.  
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 However, this study has several limitations to address. One of the largest 
limitations is the unpredictability of a natural disaster itself. Not being able to predict 
when or where a disaster event will occur, or how severe the event will be, makes it 
difficult to present a concrete, detailed plan for this initiative. However, it is the hope that 
through consideration for two broad disaster event scenarios, as well as the ability to 
evaluate system variables and patient satisfaction during and after each disaster event, the 
oncology unit assembly will become more detailed and comprehensive as the initiative 
continues.  
 In addition, this initiative proposes providing continued care for patients with a 
previously diagnosed cancer, excluding those who may have cancer but have not yet been 
seen by a primary oncologist. Due to ease of unit deployment, financial restraints, and 
proposal feasibility, this unit lacks diagnostic capabilities, leaving this sub-group without 
oncology care. In addition, because of the inability to confirm diagnoses, patients must be 
informed about their own illness, including diagnosis and previous treatments, or be 
ineligible for continued treatment as well. In areas where healthcare literacy is low, these 
constraints may exclude a large population of patients, decreasing the generalizability of 
the initiative. Countries where health literacy is high are often wealthier, with increased 
access to providers and other oncology resources at baseline. Data from these countries 
may show decreased interruptions in care leading to better morbidity and mortality 
outcomes; however, these data may be skewed as a result of this, missing the 
uninterrupted disparities in treatment continuity that exist in lower socioeconomic regions 
of the world.  
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Lastly, this proposal has limitations with regard to the study sample and patient 
recruitment. Due to the nature of this initiative, the sample population is one of 
convenience, which is not wholly representative of patients with oncology in disaster 
event situations, ultimately decreasing the generalizability of the initiative evaluation. In 
addition, recruitment for this initiative relies on both provider buy-in before the event 
occurs, as well as word of mouth during the recovery process. Those with poor primary 
follow up, or those isolated due to disaster destruction, may not be well informed of the 
services offered.  
While this study has limitations from a research perspective, one of the largest 
obstacles anticipated from a logistics perspective is one of financial constraints. 
Depending on location and severity of the disaster event, budget allocation for the 
oncology unit may come from a local, state, regional, or global party. Financial 
considerations for personnel, resources, and medications need to be made, and 
reimbursements for hours worked and equipment utilized will need careful 
documentation30; a task that is difficult when working in a recovery zone. However, 
while the cost of deploying a specialized oncologic unit to a disaster site may seem 
immense, the economic toll an NCD like cancer takes during and after a disaster event 
outweighs the upfront cost.   
 
Summary and Public Health Significance  
Cancer is now the second-largest cause of morbidity and mortality globally. Estimates 
from 2012 show that over 36.2 million individuals were living with a cancer diagnosis, 
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with over 8.2 million annual deaths deaths as a result of cancer worldwide, and the 
numbers are only increasing.19,27 These numbers are astonishing, showing that, along 
with CVD, diabetes, and respiratory illnesses, non-communicable diseases have become 
an enormous burden to the healthcare field. And yet, few studies have examined the 
importance of complete and timely oncology treatment plans, and the effects 
interruptions in these plans have on long-term patient morbidity and mortality. However, 
from the ones that have been completed, it is evident that delays in both initiating 
treatment, as well as prolongation of or interruptions in treatment plans, lead to poorer 
disease control and less disease-free survival years. As this literature review highlights, 
disaster events do in fact cause widespread obstacles as they pertain to healthcare access, 
treatment availability, and exacerbation of disease and disease comorbidities. From this, 
it can therefore be concluded that acute environmental disaster events will generate 
barriers to cancer care access, interruptions in cancer treatment plans, and ultimately 
poorer morbidity and mortality outcomes for these patients.  
 Knowing this, this study proposes guidelines for incorporating oncology care into 
disaster relief situations in an attempt to decrease interruptions in treatment plans, 
provide necessary resources, such as anti-emetics and access to sterile environments in an 
attempt to decrease patient morbidity, and ultimately lessen long-term mortality in an 
already vulnerable population. While traditional disaster relief responses have focused on 
the tangible and immediate effects of an environmental disaster, this proposal forces 
global response efforts to consider those with debilitating chronic conditions when 
planning, preparing, and responding to an event as well.   
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 Due to the novel nature of this research, there is much to be studied in the future. 
While this proposal hopes to decrease treatment plan interruptions, the initiative does not 
propose a way to evaluate the long-term intervention effects on morbidity and mortality. 
In addition, this initiative puts forth a proposal for oncology care in the wake of an acute 
disaster event; one where recovery commitments are shorter in duration. Additional 
proposals for providing care during CHEs must be researched and established to provide 
much needed care for those where the recovery process may take years.  
However, despite what needs to come, this proposal places a vulnerable 
population at the forefront of the minds of those planning and responding to disaster 
events. With an increase in all non-communicable diseases, not just cancer, it is 
becoming more and more important to consider these patients and provide necessary 
recovery resources when primary healthcare access is acutely disrupted. In doing so, it is 
the hope that unnecessary morbidity and mortality may be prevented.  
  
	  41 
APPENDIX 1 
 
Hypothetical standardized form layout for clarification regarding patient identification 
numbers  
 
 
  	    
FORM A Patient Identification 
Number 
000-000-001 
System variable questionnaire  
FORM B Patient Identification 
Number 
000-000-001 
Patient 
Name  
  
Date of 
Birth  
  
Address    
Contact 
Phone  
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APPENDIX 2 
Calculation for worldwide, 5-year prevalence rates for all cancers, excluding non-
melanoma skin cancers.  
 
Worldwide, 5 − year	  cancer	  prevalence	  rate = 	  World, 5 − year	  cancer	  prevalence ∗World	  population	  estimate ∗∗ 	  	  
 =	   32,455,0007,380,000,000 	  𝑥	  100 
 = 0.44% 
 *	  World,	  5-­‐‑year	  cancer	  prevalence19	  **	  World	  population	  estimate31	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